Ads
-
Related paper
- Ocular Manifestations in Rheumatoid Arthritis and their Co-Relation with Anti Cyclic Citrullinated Peptide Antibodies
- Study of Prognostic Value of Rheumatoid Factor and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Rheumatoid Arthritis
- THE FEATURE OF COURSE RHEUMATOID ARTHRITIS IN PATIENT WITH THE HIGH LEVEL OF ANTIBODIES TO CYCLIC CITRULLINATED PEPTIDE
- Effects of silymarin as adjuvant drug on serum levels of CTRP3, anti-cyclic citrullinated peptide (CCP), and high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis patients
- Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs
- Observational Study of Magnitude of Ocular Manifestations of Rheumatoid Arthritis in A Tertiary Care Hospital in East India
- VALIDITY OF ANTI-CCP ANTIBODIES AS MAJOR IMMUNOLOGICAL MARKER OF RHEUMATOID ARTHRITIS PATIENTS IN THI-QARPROVINCE IRAQ
- Cutaneous manifestations of Pellagra in a patient with rheumatoid arthritis
- Clinical Manifestations of Periodontal Tissue Diseases in Patients with Rheumatoid Arthritis Who Live in Anthropogenically Loaded Areas
- Management of Rheumatoid Arthritis and Effectiveness of Disease Modifying Anti-Rheumatic Drug Therapy